August 24, 2016 / 10:22 AM / a year ago

BRIEF-Prometic Life Sciences to acquire Telesta Therapeutics

1 Min Read

Aug 24 (Reuters) - ProMetic Life Sciences Inc :

* ProMetic announces agreement to acquire Telesta Therapeutics Inc in all share transaction

* Will acquire all of share capital of Telesta at a share price of $0.14 payable in ProMetic common shares

* Deal does not materially affect ProMetic's EBITDA and operating cash flows

* Agreement also contains no shop provisions and a mutual $2.5 million breakup fee payable by Telesta or ProMetic in specified circumstances Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below